Income Taxes (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
USD ($)
| |
| Income Taxes (Details) [Line Items] | |
| Net operating loss carry forwards | $ 3,043,768 |
| Federal net operating loss carry forwards | $ 3,043,768 |
| Taxable income percentage | 80.00% |
| Effective tax rate | 26.135% |
| Valuation allowance | $ 1,161,745 |
| Valuation allowance increased | $ 767,553 |
| Domestic Research [Member] | |
| Income Taxes (Details) [Line Items] | |
| Amortize research and development | 5.00% |
| Foreign Research [Member] | |
| Income Taxes (Details) [Line Items] | |
| Amortize research and development | 15.00% |
| X | ||||||||||
- Definition It represents percentage of amortize specified research and development. No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Taxable income percentage. No definition available.
|
| X | ||||||||||
- Definition Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|